https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Zoster. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/ https://globalinfectiousdisease.com/research/articles/10-1007-s12311-026-02074-3-199c1b40/ Thu, 27 Aug 2026 00:00:00 GMT The review maps the clinical spectrum of an immune-mediated post-infectious neurological syndrome across age groups and common viral triggers, which may inform recognition of ataxia syndromes following infection. COVID-19 SARS Varicella Influenza Zoster Treatment Vaccination Systematic review https://globalinfectiousdisease.com/research/articles/10-14744-ortst-2026-57654-dbcef60f/ https://globalinfectiousdisease.com/research/articles/10-14744-ortst-2026-57654-dbcef60f/ Wed, 26 Aug 2026 00:00:00 GMT The article describes postoperative herpes zoster as a potential diagnostic consideration in an older patient with acute pain after hip arthroplasty. It also reports that vaccination status was discussed in relation to higher-risk populations. Varicella Zoster Vaccination Treatment Journal article https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080722-03129fec/ https://globalinfectiousdisease.com/research/articles/10-3390-vaccines14080722-03129fec/ Fri, 21 Aug 2026 00:00:00 GMT Documented reductions in marker concentrations over time highlight potential durability considerations, informing policy deliberations regarding standardized childhood immunization schedules. Varicella Zoster Vaccination Cross-sectional study https://globalinfectiousdisease.com/research/articles/10-1371-journal-pgph-0006013-e7f7fafa/ https://globalinfectiousdisease.com/research/articles/10-1371-journal-pgph-0006013-e7f7fafa/ Tue, 18 Aug 2026 00:00:00 GMT Widespread adult susceptibility points to potential vulnerabilities for severe clinical outcomes in mature cohorts and expectant mothers, underscoring the potential value of introducing pediatric vaccination initiatives. Varicella Zoster Surveillance Vaccination Health policy Cross-sectional study https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1884479-77962d08/ https://globalinfectiousdisease.com/research/articles/10-3389-fpubh-2026-1884479-77962d08/ Mon, 17 Aug 2026 00:00:00 GMT Enhancing professional guidance within retail pharmacy settings may help mitigate persistent disease burden in aging populations by facilitating greater immunization participation. Zoster Vaccination Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106784-7587e5cb/ https://globalinfectiousdisease.com/research/articles/10-1016-j-jinf-2026-106784-7587e5cb/ Sat, 01 Aug 2026 00:00:00 GMT The documented compatibility indicates potential administrative advantages for coordinating seasonal and shingles immunisations within standard adult care pathways. COVID-19 Influenza Zoster SARS Vaccination Treatment Randomised controlled trial https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128839-f5b67b79/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128839-f5b67b79/ Sat, 01 Aug 2026 00:00:00 GMT The findings highlight persistent variation in healthcare worker vaccination policies across Europe despite recent expansion. The authors note that harmonized, evidence-based policies are needed to protect both healthcare personnel and patients amid resurgence of vaccine-preventable diseases. COVID-19 Pertussis Diphtheria Influenza Tetanus Zoster Hepatitis A Tuberculosis Mumps Rubella Varicella Hepatitis B Poliomyelitis Measles Vaccination Health policy Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128842-36d8c80c/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128842-36d8c80c/ Sat, 01 Aug 2026 00:00:00 GMT The synthesized data supply real-world effectiveness metrics that inform health policy regarding vaccine deployment across varied clinical risk categories and aging populations. Zoster Vaccination Vaccine effectiveness Health policy Systematic review https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128853-09a29a52/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128853-09a29a52/ Sat, 01 Aug 2026 00:00:00 GMT The data reveal persistent gaps in immunization recognition and administration for pneumococcal and herpes zoster vaccines within the general adult demographic, highlighting opportunities for improved public health messaging. Influenza Zoster Vaccination Journal article https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128859-781cd1dc/ https://globalinfectiousdisease.com/research/articles/10-1016-j-vaccine-2026-128859-781cd1dc/ Sat, 01 Aug 2026 00:00:00 GMT The findings support a practical vaccination strategy to reduce HZ and its complications in liver transplant recipients, a population at elevated immunocompromise-related risk. Zoster Vaccination Cohort study https://globalinfectiousdisease.com/research/articles/10-1017-s0950268818000444-b346227c/ https://globalinfectiousdisease.com/research/articles/10-1017-s0950268818000444-b346227c/ Mon, 12 Mar 2018 00:00:00 GMT The paper provides pre-universal-vaccination baseline context for varicella and zoster in Hong Kong. It may help readers understand age-specific disease patterns relevant to vaccination policy discussions. Zoster Varicella Transmission dynamics Vaccination Surveillance Journal article https://globalinfectiousdisease.com/research/articles/10-1093-aje-kwx245-81626767/ https://globalinfectiousdisease.com/research/articles/10-1093-aje-kwx245-81626767/ Wed, 21 Jun 2017 00:00:00 GMT The study provides evidence on the durability of protection from the live zoster vaccine, which was licensed in 2006 for persons 60 years or older and extended in 2011 to include persons aged 50-59 years, informing vaccination policy decisions. Zoster Vaccination Cohort study